首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Duke law journal

缩写:

ISSN:0012-7086

e-ISSN:1939-9111

IF/分区:2.0/Q1

文章目录 更多期刊信息

共收录本刊相关文章索引97
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Nicholas Hailey Nicholas Hailey
Professional cycling has suffered from a number of doping scandals. The sport's governing bodies have responded by implementing an aggressive new antidoping program known as the biological passport. Cycling's biological passport marks a dep...
Allen Rostron Allen Rostron
Over the past two decades, courts have consistently ruled that the manufacturer of a brand-name prescription drug cannot be liable for injuries suffered by those taking generic imitations of its product. This meant that a patient injured by...
Katherine L Record Katherine L Record
This Note identifies a discrepancy in the law governing the decisionmaking that directs patient care. Seeking treatment that a third party will pay for, a patient needs not only a physician-prescribed course of treatment but also an insurer...
Douglas S Curran Douglas S Curran
Fetal homicide laws criminalize killing a fetus largely to the same extent as killing any other human being. Historically, the common law did not generally recognize feticide as a crime, but this was because of the evidentiary "born-alive" ...
Anup Malani Anup Malani
A growing scientific literature supports the existence of placebo effects from a wide range of health interventions and for a range of medical conditions. This Article reviews this literature, examines the implications for law and policy, a...
Doriane Lambelet Coleman,James E Coleman Jr Doriane Lambelet Coleman
Doriane Lambelet Coleman Doriane Lambelet Coleman
Since the mid- to late 1990s, the scientific and medical research community has sought to increase its access to healthy children for research protocols that involve harm or a risk of harm. This move reverses longstanding policy within that...